Ethyl 2-(3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161798-01-2 Purity >99.0% Febuxostat Intermedia Factory
Ruifu Chemical Supple Febuxostat intermedia:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS, 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl) -4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161797-99-5
Nomen chemicum | Ethyl 2-(3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus |
Synonyma | 2-(3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylic Acidum Ethyl Ester;Febuxostat intermedia |
CAS Number | 161798-01-2 |
CATTUS Number | RF-PI1111 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C14H13NO4S |
M. Pondus | 291.32 |
Liquescens punctum | 113.0 ad 117.0℃ |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Yellow ad lux flavo pulveris |
Solubilitas | 1.0g sample dichloromethanum et dimethyl sulfoxide dissolvi potest |
UV Lepidium sativum | Maxima effusio in 260nm±3nm et 321nm±3nm aequalitatem |
Humor (KF) | ≤0.50% |
Residere in Ignition | ≤0.50% |
Ignota Unius immunditia | ≤0.50% |
Totalis immunditias | ≤1.0% |
Puritas / Analysis Methodus | ≥99.0% (Ratio anhydrous basis) |
Test Standard | Enterprise Standard |
Consuetudinem | Medium Febuxostat (CAS: 144060-53-7); |
sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore
Ethyl 2-(3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus (CAS: 161798-01-2) medium est Febuxostat (CAS: 144060-53-7).Febuxostat nova generatio xanthine oxydatis inhibitoris a Tejin Co (Iaponia) adhibita est ad longum tempus curationis hyperuicemiae (podagrae,) nova et efficacissima inhibitoris oxydi xanthine-purini selectivi.Podagricis sine hyperuricemia non commendatur.